BLFS Biolife Solutions Earnings and EPS analysis

Relative Growth: Rel. Growth: 91

Relative Strength: Rel. Strength: 93

Relative Valuation: Rel. Valuation: 52

Relative Profitability: Rel. Profitability: 77

EPS in 2026 (TTM): $1.19

Last Report Period Date: Jun 30, 2026

As of September 2026, BLFS's current EPS stands at $1.19, according to the latest financial reports. For the year 2025, the company recorded an earnings per share (EPS) of -$0.09, which marks an increase compared to its EPS of -$0.44 in 2024. BLFS reported an EPS of $0.92 for the quarterly report ending on Jun 30, 2026.

BLFS earnings history

Historical annual and quarterly earnings per share (EPS) data for Biolife Solutions

EPS (TTM)

$1.19

EPS Growth YoY (Quarterly)

378.8%

EPS (Quarterly)

$0.92

EPS Growth (Quarterly)

4,500%

For 2025, Biolife Solutions's EPS was -$0.09, an increase of 79.5% from -$0.44 in 2024. For the fiscal quarter that ended on Jun 30, 2026, the per-share earnings was $0.92, showing a 378.8% increase from the same quarter last year. For the twelve months ending June 2026, the EPS is $1.19. For the year 2024, the yearly earnings per share was -$0.44, marking an increase of 71.6% from 2023.

BLFS EPS vs price chart

BLFS EPS growth history

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

378.8%

EPS growth YoY

79.5%

EPS growth 3Y avg

N/A

EPS growth 5Y avg

N/A

During the last 12 months, Biolife Solutions has seen an EPS growth of 378.8% (YoY, quarterly).

BLFS Earnings Waterfall

Breakdown of revenue, profit and net income for Biolife Solutions

BLFS Earnings vs Peers

What are the earnings of BLFS compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
BLFS Biolife Solutions Inc	31.71	79.5%	N/A	N/A
CE Celanese Corp - Series A	N/A	24.6%	N/A	N/A
ENTA Enanta Pharmaceuticals Inc	N/A	29.9%	N/A	N/A

All data is based on quarterly TTM periods, unless otherwise specified.